Western researcher Patrick O’Donoghue advances Huntington’s disease research with tRNA-based strategies to suppress toxic proteins and improve treatments.

An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease was presented today at the ISSCR 2026 Annual Meeting.

PRECISE-HD Study. Focused on further evaluating the efficacy and safety of pridopidine, an investigational medicinal product ...

Huntington’s disease (HD) is one of those rare conditions that affects not just the patient but the entire family—medically, emotionally and genetically. This inherited brain disorder causes gradual ...

Study finds β-blockers may delay onset and slow progression of Huntington's disease, offering potential as a therapeutic strategy Study: β-Blocker Use and Delayed Onset and Progression of Huntington ...

Huntington’s disease (HD) has long been impossible to cure, but new research is finally giving fresh hope. HD is a progressive, hereditary brain disease that affects movement, cognition and emotions.

Huntington’s disease is a neurological (brain) condition that causes involuntary movement, changes to emotions, behavior, and thinking. Huntington’s is a genetic disease that worsens over time.

While Huntington’s disease is progressive and worsens over time, understanding what is to come can help someone with this condition plan for the road ahead. Huntington’s disease is a neurodegenerative ...